[Federal Register Volume 73, Number 225 (Thursday, November 20, 2008)]
[Notices]
[Pages 70356-70357]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-27532]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of Biotechnology Activities, Office of Science Policy, 
Office of the Director; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of 
the National Science Advisory Board for Biosecurity (NSABB). Under 
authority 42 U.S.C. 217a, Section 222 of the Public Health Service Act, 
as amended, the Department of Health and Human Services established 
NSABB to provide advice, guidance and leadership regarding federal 
oversight of dual use research, defined as biological research with 
legitimate scientific purposes that could be misused to pose a 
biological threat to public health and/or national security.
    The meeting will be open to the public, however pre-registration is 
strongly recommended due to space limitations. Persons planning to 
attend should register online at www.biosecurityboard.gov/meetings.asp 
or by calling Capital Consulting Corporation (Contact: Saundra Bromberg 
at 301-468-6004, ext. 406). Individuals who plan to attend and need 
special assistance, such as sign language interpretation or other 
reasonable accommodations, should indicate these requirements upon 
registration.

    Name of Committee: National Science Advisory Board for 
Biosecurity
    Date: December 10, 2008
    Open: 8:30 a.m. to 6 p.m.
    Agenda: Presentations and discussions regarding: (1) Preliminary 
findings and recommendations on strategies to optimize programs of 
personnel reliability for individuals with access to select agents 
and toxins; (2) brief overview of Public

[[Page 70357]]

Consultation meeting in July 2008 on the proposed framework for the 
oversight of dual use research; (3) brief update on the activities 
of the Working Group on Outreach and Education; (4) brief update on 
Synthetic Genomics; (5) highlights from the November 2008 
International Roundtable on Sustaining Progress in the Life 
Sciences: Strategies for Managing Dual Use Research of Concern; (6) 
public comments; and (7) other business of the Board.

    Place: The Legacy Hotel & Meeting Centre, 1775 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Ronna Hill, NSABB Program Assistant, 6705 
Rockledge Drive, Bethesda, Maryland 20892, (301) 496-9838.
    This meeting will also be webcast. The draft meeting agenda and 
other information about NSABB, including information about access to 
the Web cast and pre-registration, will be available at http://www.biosecurityboard.gov/meetings.asp. Please check the OBA Web site 
for updates. Times are approximate and subject to change.
    Any member of the public interested in presenting oral comments 
at the meeting may notify the Contact Person listed on this notice 
at least 10 days in advance of the meeting. Interested individuals 
and representatives of an organization may submit a letter of 
intent, a brief description of the organization represented and a 
short description of the oral presentation. Only one representative 
of an organization may be allowed to present oral comments. Both 
printed and electronic copies are requested for the record. In 
addition, any interested person may file written comments with the 
committee. All written comments must be received by December 1, 2008 
and should be sent via e-mail to [email protected] with ``NSABB 
Public Comment'' as the subject line or by regular mail to 6705 
Rockledge Drive, Suite 750, Bethesda, MD 20892, Attention Ronna 
Hill. The statement should include the name, address, telephone 
number and, when applicable, the business or professional 
affiliation of the interested person.

    Dated: November 13, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-27532 Filed 11-19-08; 8:45 am]
BILLING CODE 4140-01-P